Top Markets
#1 Velas Velas +367.73%
#2 Gravity Gravity +49.04%
#3 Galxe Galxe +34.81%
#4 Derive Derive +31.02%
#5 Infinity Ground Infinity Ground +29.01%
#6 Audiera Audiera +25.57%
#7 Wiki Cat Wiki Cat +25.37%
#8 Wrapped QUIL Wrapped QUIL +22.19%
#9 Aria.AI Aria.AI +21.09%
#10 Fetch.ai Fetch.ai +20.92%
Coin of the day
Velas Velas
Setări
Limbă
ROMâNă
Monedă
USD
Temă
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Rang în acțiuni #20716
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel... MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Preț acțiune
$0.00001
Capitalizare de piață
$50.01K
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează MultiCell Technologies, Inc. (MCET)

Categorie

Healthcare
Capitalizare de piață
Venituri
mai mult
Profituri
Istoric prețuri
Raport P/E
Raport P/S
Raport P/B
Marjă operațională
EPS
Divizări de acțiuni
Dividende
Randament dividend
Acțiuni în circulație
Raport P/S pentru MultiCell Technologies, Inc. (MCET)
Raport P/S la data de March 2026 TTM: 1.01K
Conform celor mai recente rapoarte financiare și prețului acțiunilor MultiCell Technologies, Inc., raportul P/S actual (TTM) este 1.01K. La sfârșitul anului 2013, compania avea un P/S de 27.21.
Istoricul raportului P/S pentru MultiCell Technologies, Inc. din 2013 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
2026 (TTM) 1.01K 3,255.43%
2014 30.22 11.07%
2013 27.21 0.00%
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
3.55 -99.65%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.90 -99.02%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.40 -99.47%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.14 -99.39%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.04 -99.70%
AU